Clinical Trial Update: Head and Neck Cancer Registry (LORHAN)

View source ↗

Summary

The Head and Neck Cancer Registry (LORHAN) study sponsored by Eli Lilly has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Snippet

Sponsor: Eli Lilly and Company | Conditions: Head and Neck Cancer | Status: COMPLETED